U. S. clinicians perform more than 50 million Pap smears each year to screen women for cervical cancer. But the test, which involves microscopically examining cells from the cervix, misses a notoriously high proportion (estimates range up to 40 percent) of abnormalities. Cambridge University researchers have devised a new screening tool that they hope will cut down on these missed opportunities to catch cancer while it’s still curable.
The tool is a stain that selectively marks proliferating-thus potentially cancerous-cervical cells, making them readily visible among their nondividing normal counterparts. In small preliminary tests, the new stain helped researchers catch cervical abnormalities with 100 percent efficiency. The Cancer Research Campaign, the British charity that funded the research, has licensed the stain to Santa Clara, Calif.-based diaDexus. The company expects to have it on the market “within a couple of years.”
A Roomba recorded a woman on the toilet. How did screenshots end up on Facebook?
Robot vacuum companies say your images are safe, but a sprawling global supply chain for data from our devices creates risk.
A startup says it’s begun releasing particles into the atmosphere, in an effort to tweak the climate
Make Sunsets is already attempting to earn revenue for geoengineering, a move likely to provoke widespread criticism.
10 Breakthrough Technologies 2023
These exclusive satellite images show that Saudi Arabia’s sci-fi megacity is well underway
Weirdly, any recent work on The Line doesn’t show up on Google Maps. But we got the images anyway.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.